HELD 9-10 DECEMBER 2021

ACCESS THE RECORDED CONTENT BELOW

This two-day virtual conference looking at the challenges and future of infection management and how we can rise to meet the challenge of antimicrobial resistance.

This conference is RCPath CPD accredited.

Programme

OPENING LECTURE
Chair: Dr David Jenkins Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
Video of session
This session consists of the following presentations:
-
State of the nation & lessons for pandemic preparedness
Dr Susan Hopkins, Consultant, UKHSA (formerly PHE)/ DHSC / Royal Free Hospital - View Bio
-
Q&A

SESSION ONE: Prevention, diagnosis, treatment - accelerated learnings from the pandemic
Chair: Dr Susan Hopkins, Consultant, UKHSA (formerly PHE)/ DHSC / Royal Free Hospital - View Bio
Video of Session
This session consists of the following presentations:
-
AMS Challenges in Africa and the way forward
Dr Mirfin Mpundu, Director ReAct Africa Partnership & Engagement Lead, International Centre for Antimicrobial Solutions (ICARS) Honorary Research Fellow, University of KwaZulu Natal - View Bio
-
COVID-19: Learnings for Surveillance and Stewardship
Professor Sabiha Essack, South African Research Chair in Antibiotic Resistance & One Health Professor, College of Health Sciences, University of KwaZulu-Natal - View Bio
-
Embedding IPC in the UK’s Healthcare Infrastructure Plan
Professor Jennie Wilson, Richard Wells Research Centre, University of West London - View Bio
-
Q&A

SESSION TWO: PARALLEL SESSIONS
PARALLEL SESSION 1: Antimicrobial Susceptibility Testing
Chair: Dr Mandy Wootton, Consultant Scientist/Operational Manager, Specialist Antimicrobial Chemotherapy Unit (SACU), Public Health Wales
-
Video of session
This session consists of the following presentations:
-
Susceptibility testing of Neisseria gonorrhoeae
Rachel Pitt-Kendall, UK HSA, Antimicrobial resistance in STIs - View Bio
-
Susceptibility testing of Neisseria meningitidis
Miss Laura, Campbell, Senior Clinical Biomedical Scientist, Public Health Wales - View Bio
-
Q&A
PARALLEL SESSION 2: New frontiers in drug development
Chair: Dr Erin Duffy, Chief of Research & Development, CARB-X
Supported by: CARB-X
-
Video of session
This session consists of the following presentations:
-
SMT026738 - A Novel Small Molecule Inhibitor of Bacterial Lipoprotein Transport
Dr Elena Breidenstein, Director, Anti-Infectives Research at Summit Therapeutics - View Bio
-
Novel Immunotherapies to treat Gram negative infections
Dr. Michael Westby, CEO, Centauri Therapeutics - View Bio
-
GonoVac, a vaccine to prevent gonorrhea and combat spread of AMR
Professor Cal MacLennan, Jenner Institute - View Bio
-
Combatting Antimicrobial Resistance with Next-Generation Diagnostics for Sepsis
Dr Dan Rogerson, CSO, GenomeKey - View Bio
-
Q&A

SESSION THREE: Cefiderocol usage in the UK: The First Year and Beyond
Chair: Mrs Fran Garraghan, Lead Antimicrobial Pharmacist, Manchester University NHS Foundation Trust - View Bio
Supported by: Shionogi
Video of session
This session consists of the following presentations:
-
Welcome & introduction
Mrs Fran Garraghan, Lead Antimicrobial Pharmacist, Manchester University NHS Foundation Trust - View Bio
-
Cefiderocol for the treatment of Achromobacter sp. in Cystic Fibrosis
Dr Felicia Lim, Consultant Medical Microbiologist, University Hospitals of Leicester NHS Trust
-
Difficult to treat infections in critical care: a complex case study
Dr Luke Moore, Consultant in Infectious Diseases and Clinical Microbiology and Virology Chelsea and Westminster NHS Foundation Trust, & Stephen Hughes, Consultant Antimicrobial Pharmacist, Chelsea and Westminster Hospital NHS Foundation Trust
-
Q&A

SESSION FIVE: 50TH ANNIVERSARY LECTURE
Chair: Professor Alasdair MacGowan, Consultant in Infection at North Bristol NHS Trust and Professor of Antimicrobial Therapeutics at the University of Bristol - View Bio
Video of session
This session consists of the following presentations:
-
50 years at the forefront of Antimicrobial Chemotherapy
Professor Dilip Nathwani OBE, Honorary Emeritus Professor of Infection, University of Dundee - View Bio

SESSION SIX: Garrod Lecture
Chair: Dr David Jenkins Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
Video of session
This session consists of the following presentations:
-
No Time To Wait: Global Action on AMR
Professor Dame Sally Davies, UK Government Special Envoy on Antimicrobial Resistance, UK Department of Health and Social Care - View Bio

SESSION SEVEN: Access, excess, inequality and antibiotic resistance
Chair: Professor Laura Piddock, Scientific Director, GARDP - View Bio
Video of session
This session consists of the following presentations:
-
Inequality in antibiotic resistance
Professor Marc Mendelson, Professor of Infectious Diseases, University of Cape Town. Chair MAC-AMR, Co-chair SA Antibiotic Stewardship Programme - View Bio
-
Managing access and excess to tackle antimicrobial resistance
Professor Debra Goff, Infectious Diseases Specialist, The Ohio State University Wexner Medical Center & The Ohio State University College of Pharmacy - View Bio
-
Barriers to access and how to overcome them
Dr Manica Balasegaram, Executive Director, GARDP - View Bio
-
Q&A

SESSION EIGHT: Clinical case studies
Chair: Sally Tipping, Lead antimicrobial pharmacist, Royal Devon and Exeter Hospital
Video of session
-
Trends in antimicrobial resistance amongst pathogens isolated from blood and cerebrospinal fluid cultures in Pakistan (2011-2015): A retrospective cross-sectional study
Ms Nida Javaid, PhD student, Lahore University of Management Sciences
-
Antibiotic prescribing practices in primary healthcare in sub-Saharan Africa: A systematic review and our experience on the use of telemedicine in Zambia
Ms Moe Takenoshita, The Virtual Doctors + University of Cambridge Medical School
-
The impact of COVID-19 infection prevention and control measures on transmission of hospital acquired infections and antimicrobial resistance in Africa
Dr Linzy Elton, Postdoctoral research associate, University College London - View Bio
-
A systematic review of the effect of therapeutic drug monitoring on patient health outcomes during treatment with penicillins.
Mr Timothy Luxton, PhD Student, University of Leeds - View Bio

SESSION NINE: Invited lectures
Chair: Dr Esmita Charani, Senior Lead Pharmacist, Imperial College London - View Bio
Video of session
-
The role of behaviour change science in helping to contain and control AMR
Professor David Halpern, Chief Executive, The Behavioural Insights Team - View Bio
-
The “One Health” approach to addressing AMR
Professor Peter Collignon, Senior Specialist and Professor Infectious Diseases and Microbiology, Canberra Hospital and Australian National University - View Bio
-
Q&A


SESSION ELEVEN: De-linkage: the whys and wherefores
Chair: Ms Laura Whitney, Regional Antimicrobial Stewardship Lead, NHSE&I - View Bio
Video of session
-
The potential of de-linkage in addressing antibacterial resistance
Professor Kevin Outterson, Professor, Boston University - View Bio
-
A practical guide to the de-linkage programme
Mr David Glover Associate director, medicines analysis team NHS England and NHS Improvement - View Bio
-
The UK Antimicrobial Registry
Dr Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio
-
Q&A

SESSION TWELVE: Clinical decision-support for antimicrobial stewardship: challenges and opportunities
Chair: Dr Monsey McLeod, Imperial College Healthcare NHS Trust - View Bio
Supported by: MSD
Video of session
-
How decision support can improve antimicrobial prescribing: evidence and innovation
Dr Philip Scott, University of Portsmouth - View Bio
-
Decision support in practice: understanding behaviours and context
Professor Susan Latter, University of Southampton - View Bio
-
Q&A

SESSION FOURTEEN: Optimal laboratory services and the role of new diagnostics
Chair: Daniel Berman , Global Health Director, Nesta Challenges - View Bio
Video of session
-
Optimal use of laboratory services - a baseline for excellence in practice
Dr Nick Brown, Consultant Medical Microbiologist, Cambridge University Hospitals NHS Trust - View Bio
-
Rapid diagnostics - the value and meaning of time?
Professor Gail Hayward, Associate Professor of Primary Care, University of Oxford & Director, NIHR Community Healthcare MIC - View Bio
-
One world laboratory and aspirations for global health
Dr David Jenkins Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
-
Q&A

Having trouble finding what you're after?

Top